Quoin Pharmaceuticals Ltd... (QNRX)
NASDAQ: QNRX
· Real-Time Price · USD
13.59
-1.68 (-11.00%)
At close: Oct 16, 2025, 3:31 PM
-11.00% (1D)
| Bid | 13.41 |
| Market Cap | 7.99M |
| Revenue (ttm) | 100.37K |
| Net Income (ttm) | -12.17M |
| EPS (ttm) | 958.65 |
| PE Ratio (ttm) | 0.01 |
| Forward PE | -0.91 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 13.59 |
| Volume | 219,639 |
| Avg. Volume (20D) | 289,726 |
| Open | 18.00 |
| Previous Close | 15.27 |
| Day's Range | 13.44 - 18.00 |
| 52-Week Range | 5.01 - 48.30 |
| Beta | 1.86 |
| Ex-Dividend Date | n/a |
About QNRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QNRX
Website n/a
6 days ago
+151.23%
Quoin Pharmaceuticals shares are trading higher. T...
Unlock content with
Pro Subscription
4 months ago
+0%
QNRX stock has given up its prior gain. Quoin Pharmaceuticals shares were trading higher after the company announced it received FDA clearance to initiate a second whole-body QRX003 netherton syndrome clinical study.
